Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Integrated Genetics/Laboratory Corporation of America | RCV000586452 | SCV000696848 | uncertain significance | not provided | 2016-09-07 | criteria provided, single submitter | clinical testing | Variant summary: The CFTR c.1544A>G (p.Tyr515Cys) variant involves the alteration of a conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant is located in the ABC transporter-like domain and the P-loop containing nucleoside triphosphate hydrolase domain of the protein (InterPro). Structural/biochemical analysis indicate that Tyr515 residue is phosphorylated in vivo (PMID: 24178769). This variant is absent in 121248 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories, nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is currently classified as a variant of uncertain significance (VUS) until additional information becomes available. |